Structured page family:Cost guide

Sermorelin Cost Guide: Insurance, Cash Pay, and Savings

In the United States, Sermorelin costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.

Active Market
This page is designed for US treatment decisions and uses US-first pricing and savings sources.
Official pricing
Verify current pricing directly on official Geref pages before starting, because list pricing, self-pay offers, and eligibility terms can change.
Cash-pay reality
Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.
Insurance coverage
Commercial coverage for Sermorelin varies by plan and indication. Prior authorization is commonly required.
Savings and coupons
Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.
Prior Authorization
Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.

Price Breakdown

List price (monthly)
Not commercially branded; compounding pricing
Average wholesale price
N/A (compounded)
Pharmacy acquisition estimate
N/A (compounded)
Typical negotiated rate
N/A (cash pay)
Price per dose
~$7-15 per 0.2-0.5 mg dose
Annual cost at list price
~$2,400-$5,400

Pharmacy Price Comparison

PharmacyPrice RangeNotes
Compounding pharmacy$200-$450/monthVaries by pharmacy and concentration
Online peptide retailers$150-$350/monthQuality varies widely; COA verification essential

Insurance Coverage Landscape

Commercial plans
<5% for off-label anti-aging
Medicare Part D
Not covered for off-label use
Medicaid
Not covered
VA coverage
Not covered for off-label
TRICARE
Not covered
Employer plan typical tier
Not covered

Prior Authorization Guide

Required Documentation
  • Pediatric GH deficiency diagnosis (rare adult coverage)
Common Denial Reasons
  • Off-label use
  • Anti-aging not medically necessary
Appeal Template Points
  • Documented GH deficiency
  • Low IGF-1
Expected timeline: N/A (virtually never covered)

Savings Programs and Patient Assistance

Compounding memberships
pharmacy
Eligibility: Cash-pay patients
Savings: 10-20% discount
Income limit: None
Enrollment: simple
Subscription models

Generic and Biosimilar Status

No generic currently available
Expected: N/A

Compounded Alternative

Compounded versions exist
Price range: $150-$450/month
Legal status: Legal when prescribed by licensed physician and compounded by registered 503A pharmacy
Quality concerns
  • No FDA oversight
  • Variable potency
  • Sterility concerns
  • Need third-party COA verification

Cost by Dose

Dose/RegimenMonthlyAnnual
0.2 mg daily$200$2,400
0.5 mg daily$450$5,400

Annual Cost Projection

Year 1
$2,400-$5,400
Year 2
$2,400-$5,400
Year 3
$2,400-$5,400
Assumptions
  • Cash pay only
  • Compounded product

Cost-Saving Strategies

  • 1.Shop multiple compounding pharmacies for best price
  • 2.Verify third-party COA before purchasing
  • 3.Avoid online retailers without prescription requirement
  • 4.Consider lower starting dose to assess response

International Price Comparison

CountryPrice RangeNotes
Mexico$100-$250/monthCompounded; quality variable

Need help comparing sermorelin paths?

Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.

Find a sermorelin provider
Trust Summary
Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 3 official sources.
Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.

Sermorelin Cost FAQ

Sources

  1. 1. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.
    BioDrugs • 1999
    Claim type: review
    View source →
  2. 2. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    J Clin Endocrinol Metab • 1997
    Claim type: review
    View source →
  3. 3. FDA Information on Sermorelin
    FDA • 2026
    Claim type: regulatory
    View source →

This content is for informational purposes only and does not constitute medical advice.